Optimal versus suboptimal mitral valve repair: late results in a matched cohort study

Michele De Bonis1,2, Edoardo Zancanaro2, Elisabetta Lapenna2

  • 1School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.

Abstract

Insights

Suboptimal mitral repair for degenerative mitral regurgitation (MR) leads to lower durability and increased need for medication. Even optimal repairs do not halt MR progression, highlighting the chronic nature of the condition.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes
  • Mitral Valve Repair

Background:

  • Degenerative mitral regurgitation (MR) requires repair, with ideal outcomes aiming for no or mild residual MR (≤1+/4+).
  • Occasionally, patients have more than mild residual MR (>1+/4+) after mitral repair due to various factors.
  • Assessing the long-term consequences of suboptimal mitral repair is crucial for patient management.

Purpose of the Study:

  • To evaluate the late implications of mitral repair resulting in more than mild residual MR.
  • To compare outcomes between patients with suboptimal repair and those with optimal repair (≤1+ MR).

Main Methods:

  • A matched cohort study included 50 patients with residual MR >1+ (study group) and 91 patients with MR ≤1+ (control group).
  • Patients underwent mitral repair for degenerative MR between 2006 and 2013.
  • Median follow-up was 8 years, with comparative analysis of survival, reoperation, and MR progression.

Main Results:

  • Overall survival at 8 years was similar between groups (87% ± 8% vs. 92% ± 3%, P=0.23).
  • Freedom from reoperation was also similar (P=1.0).
  • The prevalence of severe MR (≥3+) was significantly higher in the suboptimal repair group (15.6% vs. 2.1%, P<0.001), along with increased medication use. Even optimal repairs showed MR progression over time.

Conclusions:

  • Mitral repair with residual MR >1+ is linked to reduced long-term durability and increased medical therapy needs.
  • Optimal initial mitral repair results do not prevent the progression of degenerative MR.
  • Continuous monitoring and management are essential even after successful mitral valve repair.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
178
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
154
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
197
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
288
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
269
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
235